| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.78B | 37.45B | 36.72B | 37.67B | 37.01B | 43.81B |
| Gross Profit | 12.75B | 12.52B | 12.26B | 13.31B | 13.06B | 13.72B |
| EBITDA | 11.78B | 11.61B | 14.78B | 25.79B | 16.86B | 21.01B |
| Net Income | -4.40B | -4.17B | 1.14B | 11.84B | 2.24B | 59.00M |
Balance Sheet | ||||||
| Total Assets | 128.86B | 138.83B | 144.35B | 168.97B | 171.40B | 155.06B |
| Cash, Cash Equivalents and Short-Term Investments | 13.53B | 19.90B | 10.53B | 20.34B | 17.16B | 11.87B |
| Total Debt | 53.91B | 57.41B | 58.51B | 72.13B | 77.99B | 66.80B |
| Total Liabilities | 72.25B | 80.59B | 83.35B | 98.91B | 107.90B | 97.25B |
| Stockholders Equity | 52.82B | 56.98B | 59.97B | 68.88B | 60.95B | 55.80B |
Cash Flow | ||||||
| Free Cash Flow | 10.23B | 8.67B | 9.70B | 13.10B | 13.53B | 11.80B |
| Operating Cash Flow | 14.23B | 15.37B | 16.56B | 18.05B | 18.08B | 17.21B |
| Investing Cash Flow | 43.81M | 4.76B | -6.12B | -379.00M | -6.87B | -9.26B |
| Financing Cash Flow | -13.83B | -15.28B | -15.86B | -13.43B | -9.71B | -15.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $235.08B | 20.84 | 18.18% | 1.75% | 7.30% | 17.67% | |
72 Outperform | $213.08B | 10.02 | 16.62% | 6.60% | 2.42% | 102.17% | |
67 Neutral | $194.97B | 8.14 | 20.35% | 4.56% | 1.98% | 150.68% | |
62 Neutral | $72.87B | 14.48 | 17.05% | 2.69% | 1.14% | 83.48% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | $34.30B | 7.35 | -8.37% | 3.77% | 19.67% | -278.51% |